Fire disrupts production at Teva plant in Croatia

Production was halted at Teva Pharmaceutical's ($TEVA) Pliva Pharmaceuticals plant in Croatia after a fire injured 9 workers, including one critically.

The company has said the fire would not create extended disruptions to production. The blaze on Friday was at the factory in Zagreb, where Pliva is based. It is believed to have been started by an electrical short circuit and was quickly extinguished by local firefighters, according to reports.

The plant produces about 80% of Pliva's products, including Adderall for attention deficit disorder, reports Globes, the Israeli business publication. Teva acquired Pliva, the largest generic pharmaceutical manufacturer in Croatia, in 2008.

Significant amounts of active ingredients for other Teva drugs are manufactured at the damaged plant. The facility also has research and development operations for pharmaceuticals sold into the European market. Pliva has about 6,000 employees.

- read the Globes story

​Related Articles:
Teva's Cephalon recalls leukemia drug over fragments in vial
Teva gets close-out letter over Jerusalem plant

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.